Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- Astellas Reduces Sales Offices from 159 to 109, Aims to Better Respond to Specific Needs in Each Region: President Hatanaka
December 12, 2014
- Hanshin Dispensing Holding Joins Forces with Convenience Store Lawson
December 12, 2014
- Brexpiprazole Improves Schizophrenia in PIII: Otsuka, Lundbeck
December 11, 2014
- Eisai’s Orexin Receptor Antagonist Improves Sleep Initiation, Maintenance in PII Study
December 11, 2014
- Blopress AG Will Lose Steam after Launch of Rival Generics, Sawai Pres. Predicts
December 11, 2014
- Ono, Kyowa Kirin, BMS to Conduct PI Study of Opdivo and Poteligeo as Combination Therapy in Patients with Solid Tumors
December 11, 2014
- Humanized Bispecific Antibody for Hemophilia A Effective in PI Study: Chugai
December 10, 2014
- Alfresa to Acquire More Shares of Pharmacy Chain Operator
December 10, 2014
- Ethical Drug Sales 1.1%, in October: Crecon Report
December 10, 2014
- Efficacy of Lenalidomide in Treatment-Naïve Patients with Multiple Myeloma Confirmed in Domestic PII Study: Celgene
December 10, 2014
- Takeda, Monash University of Australia to Collaborate in Gastroenterology Field
December 10, 2014
- Data Suggest Potential Feasibility of Ixazomib as Maintenance Therapy for Multiple Myeloma: Takeda
December 9, 2014
- Eisai’s Fycompa Cuts Tonic-Clonic Seizure Frequency by 76.5%
December 9, 2014
- Adcetris Significantly Extends PFS in Post-Transplant Hodgkin lymphoma Patients: Takeda
December 9, 2014
- Abilify Maintena Approved for Use in Acutely Relapsed Adults with Schizophrenia in the US: Otsuka, Lundbeck
December 9, 2014
- April-September Sales Drop 21.5% for Major Long-Listed Products
December 8, 2014
- Daiichi Sankyo to Harness Ties with Cardiologists in Lixiana Promotion
December 8, 2014
- Pfizer Japan Launches CML Drug Bosulif
December 8, 2014
- Zenyaku Kogyo to Initiate Preclinical Study for Nucleic Acid Medicine for Psoriasis as Early as Next Year
December 8, 2014
- COPD Drug Ultibro Launched in UK
December 8, 2014
ページ
As many as 47 new drug candidates are expected to win approval or secure NHI price listing in Japan in…
Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…